TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 56 filers reported holding TREVI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,733 | -5.0% | 708,593 | +4.1% | 0.00% | – |
| Q2 2023 | $1,626,617 | +783.3% | 680,593 | +583.7% | 0.00% | – |
| Q1 2023 | $184,153 | -52.1% | 99,542 | -50.0% | 0.00% | – |
| Q4 2022 | $384,232 | +222.9% | 199,084 | +158.4% | 0.00% | – |
| Q3 2022 | $119,000 | +6.2% | 77,042 | +93.4% | 0.00% | – |
| Q2 2022 | $112,000 | +38.3% | 39,842 | +8.1% | 0.00% | – |
| Q1 2022 | $81,000 | – | 36,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |